Betterlife Pharma Inc (BETRF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 04-2022 | 01-2022 | 10-2021 | 07-2021 | 04-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,360 | -9,709 | -6,542 | -4,895 | -1,941 |
| Depreciation Amortization | 4 | 15 | 11 | 8 | 4 |
| Accounts receivable | 248 | 145 | 349 | 338 | 308 |
| Other Working Capital | 1,650 | -1,051 | -1,153 | -1,184 | -335 |
| Other Operating Activity | 141 | 1,655 | -30 | -67 | -310 |
| Operating Cash Flow | $-318 | $-8,946 | $-7,365 | $-5,800 | $-2,275 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 96 | -104 | 98 | 95 |
| Debt Repayment | N/A | -200 | N/A | -106 | N/A |
| Common Stock Issued | 197 | 9,135 | 9,104 | 9,313 | 2,353 |
| Other Financing Activity | 0 | -62 | -61 | -161 | -61 |
| Financing Cash Flow | $197 | $8,970 | $8,940 | $9,144 | $2,387 |
| Exchange Rate Effect | -5 | -10 | 1 | -13 | -17 |
| Beginning Cash Position | 137 | 124 | 123 | 126 | 123 |
| End Cash Position | 11 | 139 | 1,698 | 3,457 | 218 |
| Net Cash Flow | $-126 | $15 | $1,575 | $3,331 | $95 |
| Free Cash Flow | |||||
| Operating Cash Flow | -318 | -8,946 | -7,365 | -5,800 | -2,275 |
| Free Cash Flow | -318 | -8,946 | -7,365 | -5,800 | -2,275 |